Analysis of 119,536 UK adults found each five-unit increase in Mediterranean diet adherence reduced metabolic dysfunction-associated steatotic liver disease (MASLD) odds by 19%. Over nearly 10 years of follow-up, higher Mediterranean diet scores correlated with reduced hospitalizations for liver, cardiovascular, diabetes, respiratory, and kidney diseases, plus lower all-cause mortality risk among those with existing MASLD. This represents compelling evidence that Mediterranean dietary patterns protect against fatty liver disease even outside traditional Mediterranean populations. The protective mechanism likely involves the diet's anti-inflammatory compounds, healthy fats, and fiber content working synergistically to reduce hepatic fat accumulation and systemic inflammation. What makes this particularly significant is the demonstration of benefits in a Northern European population with different baseline dietary habits and genetic backgrounds. The dose-response relationship suggests even modest improvements in diet quality yield measurable health benefits. However, the observational design cannot establish causation, and the study relied partly on dietary recall data, which carries inherent limitations. Still, this adds substantial weight to mounting evidence positioning Mediterranean dietary patterns as a cornerstone intervention for metabolic health across diverse populations.